Haematologica (Feb 2023)
Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for <i>FLT3</i>- mutated acute myeloid leukemia patients – Czech center experience
Abstract
No abstracts available.
Haematologica (Feb 2023)